Suppr超能文献

甲状腺功能亢进症患者口服葡萄糖负荷后的血浆C肽反应。

Plasma C-peptide response to oral glucose load in hyperthyroidism.

作者信息

Bonora E, Manicardi V, Zenere M, Moghetti P, Coscelli C, Muggeo M

机构信息

Cattedra di Malattie del Metabolismo, Università di Verona, Italy.

出版信息

J Endocrinol Invest. 1990 Jul-Aug;13(7):555-8. doi: 10.1007/BF03348624.

Abstract

Aim of the present study was to evaluate the pancreatic beta cell response to oral glucose load in a group of patients with hyperthyroidism. For this purpose plasma C-peptide at fasting and after a 100 g oral glucose load was measured in 8 newly-diagnosed untreated hyperthyroid patients with fasting normoglycemia, and 8 sex-, age-, and weight-matched healthy controls. As compared to healthy subjects, patients with hyperthyroidism showed higher plasma glucose levels (incremental area 5405 +/- 742 vs 2729 +/- 539 mg/dl x 180 min, p less than 0.05), and slightly reduced plasma C-peptide concentrations (incremental area 166 +/- 12 vs 182 +/- 36 pmol/ml x 180 min, p = NS) following oral glucose load. The ratios between plasma C-peptide and plasma glucose incremental areas were lower in hyperthyroid patients than in controls (3.66 +/- 0.85 vs 10.41 +/- 3.08, p less than 0.05). These data suggest that hyperthyroidism is characterized by a decreased pancreatic beta cell response to oral glucose load.

摘要

本研究的目的是评估一组甲状腺功能亢进患者的胰腺β细胞对口服葡萄糖负荷的反应。为此,对8名新诊断的未经治疗的空腹血糖正常的甲状腺功能亢进患者以及8名性别、年龄和体重匹配的健康对照者,测量了空腹及口服100g葡萄糖负荷后的血浆C肽。与健康受试者相比,甲状腺功能亢进患者口服葡萄糖负荷后血糖水平更高(增加面积5405±742 vs 2729±539mg/dl×180分钟,p<0.05),血浆C肽浓度略有降低(增加面积166±12 vs 182±36pmol/ml×180分钟,p=无显著性差异)。甲状腺功能亢进患者血浆C肽与血浆葡萄糖增加面积的比值低于对照组(3.66±0.85 vs 10.41±3.08,p<0.05)。这些数据表明,甲状腺功能亢进的特征是胰腺β细胞对口服葡萄糖负荷的反应降低。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验